Highlights
NASDAQ: ATHX       Athersys Inc
Last Price Today's Change   Day's Range   Trading Volume
1.92   -0.09 (4.48%)  1.90 - 2.08  1,700,600

Overview

 
Avg Volume (4 weeks):2,502,005
4 Weeks Range:1.73 - 2.34
4 Weeks Price Volatility (%):
31.15%
52 Weeks Range:1.13 - 4.38
52 Weeks Price Volatility (%):
24.31%
Average Price Target: 4.00
Price Target Upside/Downside: +2.08

Headlines



No recent Headlines for this stock.


Business Background

Athersys Inc is a clinical stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3395  5701  443  114 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 0.714-0.029 
 BNGO 8.43+0.80 
 SENS 1.58-0.26 
 CCIV 18.36+0.55 
 CTRM 0.336-0.01 
 AMC 2.33+0.13 
 BB 9.84-0.84 
 OBSV 4.07+0.53 
 AVGR 1.47-0.37 
 ZOM 0.975-0.065 

TOP ARTICLES

1. Equities Retreated on Waning Optimism State of The Markets
2. Daily Futures Trading Strategy 15 January 2021 Where Futures Lies
3. Daily Futures Trading Strategy 14 January 2021 Where Futures Lies
4. Markets Mixed on Hedging State of The Markets
5. Impeachment, Stimulus And The Markets Wall Street Breakfast